17.52

0.37% 0.065

After Hours: 17.60 0.075 +0.43%

Mediwound Ltd (MDWD)

Overview News Price History Option Chain Discussions Forecast Stock Split

Mediwound Ltd stock is traded at $17.52, with a volume of 28,295. It is up +0.37% in the last 24 hours and up +8.25% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Previous Close:

$17.46

Open:

$17.52

24h Volume:

28,295

Relative Volume:

0.42

Market Cap:

$186.43M

Revenue:

$19.85M

Net Income/Loss:

$-12.75M

P/E Ratio:

-12.70

EPS:

-1.38

Net Cash Flow:

$-21.94M

1W Performance:

+1.59%

1M Performance:

+8.25%

6M Performance:

+1.39%

1Y Performance:

-1.04%

1-Day Range:

$17.34

$17.60

1-Week Range:

$17.10

$18.23

52-Week Range:

$12.78

$24.00

Mediwound Ltd Stock (MDWD) Company Profile

Name

Mediwound Ltd

Sector

Healthcare (1153)

Industry

Biotechnology (676)

Phone

Address

Employee

111

Twitter

Next Earnings Date

2025-03-19

Latest SEC Filings

MDWD's Discussions on Twitter

Compare MDWD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDWD Mediwound Ltd	17.52	186.43M	19.85M	-12.75M	-21.94M	-1.38
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-02-25	Initiated	Alliance Global Partners	Buy
Feb-28-25	Initiated	Craig Hallum	Buy
Jul-16-24	Reiterated	Maxim Group	Buy
Dec-22-22	Initiated	Maxim Group	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Sep-23-20	Initiated	BTIG Research	Buy
Nov-28-16	Initiated	Aegis Capital	Buy
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform

View All

Mediwound Ltd Stock (MDWD) Latest News

May 07, 2025

MediWound Ltd. (NASDAQ:MDWD) Shares Sold by Renaissance Technologies LLC - Defense World

May 07, 2025

May 05, 2025

Will VALUE Add More Value To MediWound? - RTTNews

May 05, 2025

MediWound to Report First Quarter 2025 Financial Results - The Manila Times

May 05, 2025

Enzymatic Therapeutics Leader MediWound Sets Q1 2025 Earnings CallKey Updates Expected - Stock Titan

May 05, 2025

MediWound (NASDAQ:MDWD) Earns Buy Rating from Analysts at Alliance Global Partners - Defense World

May 05, 2025

May 02, 2025

(MDWD) Technical Data - news.stocktradersdaily.com

May 02, 2025

MediWound (MDWD) Gains Buy Rating with Promising Future Prospect - GuruFocus

May 02, 2025

Apr 30, 2025

Geode Capital Management LLC Grows Stock Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Apr 30, 2025

Apr 28, 2025

MediWound (MDWD) to Showcase Innovative Wound Care Research at K - GuruFocus

Apr 28, 2025

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - GlobeNewswire

Apr 28, 2025

Breakthrough Wound Care Data: EscharEx Outperforms SANTYL in Latest Clinical Studies - Stock Titan

Apr 28, 2025

MediWound Ltd. (NASDAQ:MDWD) Stake Increased by Russell Investments Group Ltd. - Defense World

Apr 28, 2025

Wells Fargo & Company MN Cuts Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Apr 28, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 18, 2025

What You Can Learn From MediWound Ltd.'s (NASDAQ:MDWD) P/S - simplywall.st

Apr 18, 2025

Apr 16, 2025

Those who invested in MediWound (NASDAQ:MDWD) five years ago are up 30% - Yahoo Finance

Apr 16, 2025

Apr 07, 2025

MediWound schedules annual shareholder meeting for May 15 By Investing.com - Investing.com Canada

Apr 07, 2025

MediWound schedules annual shareholder meeting for May 15 - Investing.com Australia

Apr 07, 2025

HC Wainwright Reiterates Buy Rating for MediWound (NASDAQ:MDWD) - The AM Reporter

Mar 23, 2025

StockNews.com Upgrades MediWound (NASDAQ:MDWD) to “Sell” - Defense World

Mar 23, 2025

Mar 22, 2025

HC Wainwright Reaffirms Buy Rating for MediWound (NASDAQ:MDWD) - Defense World

Mar 22, 2025

HC Wainwright Comments on MediWound FY2029 Earnings - Defense World

Mar 22, 2025

Mar 21, 2025

When (MDWD) Moves Investors should Listen - news.stocktradersdaily.com

Mar 21, 2025